- Home
- RPTX vs AKYA Comparison
RPTX vs AKYA Comparison
Compare RPTX & AKYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPTX
- AKYA
- Stock Information
- Founded
- RPTX 2016
- AKYA 2015
- Country
- RPTX Canada
- AKYA United States
- Employees
- RPTX N/A
- AKYA N/A
- Industry
- RPTX Biotechnology: Pharmaceutical Preparations
- AKYA Medical Specialities
- Sector
- RPTX Health Care
- AKYA Industrials
- Exchange
- RPTX Nasdaq
- AKYA Nasdaq
- Market Cap
- RPTX 58.8M
- AKYA 56.1M
- IPO Year
- RPTX 2020
- AKYA 2021
- Fundamental
- Price
- RPTX $1.36
- AKYA $1.24
- Analyst Decision
- RPTX Strong Buy
- AKYA Hold
- Analyst Count
- RPTX 3
- AKYA 7
- Target Price
- RPTX $4.50
- AKYA $2.51
- AVG Volume (30 Days)
- RPTX 190.7K
- AKYA 1.1M
- Earning Date
- RPTX 05-13-2025
- AKYA 05-12-2025
- Dividend Yield
- RPTX N/A
- AKYA N/A
- EPS Growth
- RPTX N/A
- AKYA N/A
- EPS
- RPTX N/A
- AKYA N/A
- Revenue
- RPTX $1,073,000.00
- AKYA $79,961,000.00
- Revenue This Year
- RPTX N/A
- AKYA $12.57
- Revenue Next Year
- RPTX N/A
- AKYA $13.73
- P/E Ratio
- RPTX N/A
- AKYA N/A
- Revenue Growth
- RPTX N/A
- AKYA N/A
- 52 Week Low
- RPTX $0.89
- AKYA $0.93
- 52 Week High
- RPTX $4.29
- AKYA $3.42
- Technical
- Relative Strength Index (RSI)
- RPTX 55.96
- AKYA 52.88
- Support Level
- RPTX $1.33
- AKYA $1.21
- Resistance Level
- RPTX $1.41
- AKYA $1.26
- Average True Range (ATR)
- RPTX 0.06
- AKYA 0.08
- MACD
- RPTX -0.01
- AKYA 0.02
- Stochastic Oscillator
- RPTX 55.56
- AKYA 60.71
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.
About AKYA Akoya BioSciences Inc.
Akoya Biosciences Inc is a life sciences technology company. It is delivering spatial biology solutions focused on transforming discovery, clinical research and diagnostics. Its PhenoCycler (formerly CODEX) and PhenoImager (formerly Phenoptics) platforms, reagents, software, and services, It offer end-to-end solutions to perform tissue analysis and spatial phenotyping across the full continuum from discovery through translational and clinical research and diagnostics.